SLS (3205.TWO) monthly revenue, September 2026
SLS reported revenue of NT$35.8 million for September 2026, up 1.5% from the previous month and up 71.1% from a year earlier. Year-to-date revenue was NT$437.7 million, up 42.8% year on year. It ranked 18 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.04 | 1.5 | 71.1 |